Remimazolam to prevent low oxygen during hysteroscopy in overweight women
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether a sedation drug called remimazolam can reduce the risk of severe low oxygen levels during a hysteroscopy for overweight or obese women undergoing fertility treatment. If you qualify, you may receive a gentler sedation option that could be safer for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 50 years old.
- You are having a hysteroscopy (a procedure to look inside your uterus) as part of fertility treatment.
- Your overall health is good (ASA classification I or II).
- Your BMI is 23 or higher (which means you are overweight or obese).
- You do not have severe lung disease, serious liver or kidney problems, or a history of drug or alcohol abuse.
- You are not pregnant or breastfeeding, and you have no allergies to certain medications or foods.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if remimazolam, a sedative, can reduce low oxygen levels during a procedure to collect eggs from the ovaries. It may be a safer option for people having this fertility treatment.
This trial tests two different anesthesia methods for women having hysteroscopy (a procedure to look inside the uterus) as a day surgery. One method uses remimazolam, a fast-acting sedative, plus its reversal agent flumazenil, and the other uses sevoflurane, a standard inhaled gas. The goal is to see which approach helps women recover and leave the hospital sooner.
This trial tests a sedative called remimazolam for people who are at higher risk during a painless bronchoscopy (a lung exam). It aims to see if this drug is safe and effective for you.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This trial tests a sedative called remimazolam for women undergoing gynecological surgeries like hysterectomy or fibroid removal. The goal is to see how it works and if it's a good option for anesthesia.
This trial tests a sedative called remimazolam for people who need a high-risk ERCP procedure (a scope exam of the bile ducts). It is looking at whether remimazolam can provide safe and effective sedation for patients with serious health problems.
Hear when a new Hypoxia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.